Key result
Depressive co-morbidity in medical inpatients will be evaluated in a longitudinal cohort study to determine its prevalence and 6-month outcomes in primary care.
Why the study?
Does depressive co-morbidity at hospital discharge worsen quality of life, healthcare utilization, and mortality at 6-month follow-up in medical in-patients?
Does depressive co-morbidity at hospital discharge worsen quality of life, healthcare utilization, and mortality at 6-month follow-up in medical in-patients?
This paper describes the rationale and design of a prospective cohort study evaluating the 6-month outcomes of medical in-patients discharged with co-morbid depression.
Objectives: In a context of a "continuity of care" model in Psychosomatic and Liaison Psychiatry, this study is intended to test, in patients to be discharged from Medicine wards, hypotheses related to a high prevalence of depression and, in particular, its negative outcome at six-months follow-up in Primary Care (PC), specially among the elderly.
No takes yet. Share an insight, caveat, or question.
Lobo et al. (2005) studied Depressive co-morbidity in medical in-patients (n=700). Depression vs. Patients without psychiatric co-morbidity was evaluated on Chronicity index of depression, quality of life impairment, use and costs of medical services, and mortality rates at 6-month follow-up. Depressive co-morbidity in medical inpatients will be evaluated in a longitudinal cohort study to determine its prevalence and 6-month outcomes in primary care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: